Literature DB >> 24984900

Stromal fibroblasts and the immune microenvironment: partners in mammary gland biology and pathology?

Ashleigh Unsworth1, Robin Anderson, Kara Britt.   

Abstract

The microenvironment of a tumor has emerged recently as a critical contributor to the development of cancer. Within this environment, fibroblasts and immune cells are the cell lineages that seem to be active mediators of tumour development. The activated fibroblasts that are also present during wound healing and chronic inflammation have been studied extensively. Their activation leads to altered gene expression profiles that markedly increase growth factor and cytokine secretion, leading to major alterations in the immune cell microenvironment. To better understand normal tissue development, wound healing and the chronic inflammation that leads to cancer, we review here information available on the role of fibroblasts and immune cells in normal breast development and in cancer. We also discuss the immunogenicity of breast cancer compared to other cancers and the contribution of the immune microenvironment to the initiation, progression and metastasis of tumors. Also reviewed is the limited knowledge on the role of immune cells and fibroblasts in normal development and whether the risk of cancer increases when their control is not tightly regulated.

Entities:  

Mesh:

Year:  2014        PMID: 24984900     DOI: 10.1007/s10911-014-9326-8

Source DB:  PubMed          Journal:  J Mammary Gland Biol Neoplasia        ISSN: 1083-3021            Impact factor:   2.673


  150 in total

1.  Breast cancer lung metastasis requires expression of chemokine receptor CCR4 and regulatory T cells.

Authors:  Purevdorj B Olkhanud; Dolgor Baatar; Monica Bodogai; Fran Hakim; Ronald Gress; Robin L Anderson; Jie Deng; Mai Xu; Susanne Briest; Arya Biragyn
Journal:  Cancer Res       Date:  2009-06-30       Impact factor: 12.701

Review 2.  Tumor antigen-specific T helper cells in cancer immunity and immunotherapy.

Authors:  K L Knutson; M L Disis
Journal:  Cancer Immunol Immunother       Date:  2005-01-27       Impact factor: 6.968

Review 3.  Fibroblast activation protein-α: a key modulator of the microenvironment in multiple pathologies.

Authors:  Thomas Kelly; Yan Huang; Avis E Simms; Anna Mazur
Journal:  Int Rev Cell Mol Biol       Date:  2012       Impact factor: 6.813

Review 4.  Tumor-associated macrophages in breast cancer as potential biomarkers for new treatments and diagnostics.

Authors:  Rita A Mukhtar; Onouwem Nseyo; Michael J Campbell; Laura J Esserman
Journal:  Expert Rev Mol Diagn       Date:  2011-01       Impact factor: 5.225

5.  Evidence for a stromal-epithelial "lactate shuttle" in human tumors: MCT4 is a marker of oxidative stress in cancer-associated fibroblasts.

Authors:  Diana Whitaker-Menezes; Ubaldo E Martinez-Outschoorn; Zhao Lin; Adam Ertel; Neal Flomenberg; Agnieszka K Witkiewicz; Ruth C Birbe; Anthony Howell; Stephanos Pavlides; Ricardo Gandara; Richard G Pestell; Federica Sotgia; Nancy J Philp; Michael P Lisanti
Journal:  Cell Cycle       Date:  2011-06-01       Impact factor: 4.534

Review 6.  Cytokines in acute and chronic inflammation.

Authors:  C A Feghali; T M Wright
Journal:  Front Biosci       Date:  1997-01-01

7.  The aryl hydrocarbon receptor attenuates tobacco smoke-induced cyclooxygenase-2 and prostaglandin production in lung fibroblasts through regulation of the NF-kappaB family member RelB.

Authors:  Carolyn J Baglole; Sanjay B Maggirwar; Thomas A Gasiewicz; Thomas H Thatcher; Richard P Phipps; Patricia J Sime
Journal:  J Biol Chem       Date:  2008-08-12       Impact factor: 5.157

Review 8.  Oncogenes induce the cancer-associated fibroblast phenotype: metabolic symbiosis and "fibroblast addiction" are new therapeutic targets for drug discovery.

Authors:  Michael P Lisanti; Ubaldo E Martinez-Outschoorn; Federica Sotgia
Journal:  Cell Cycle       Date:  2013-07-30       Impact factor: 4.534

9.  Stromal gene expression predicts clinical outcome in breast cancer.

Authors:  Greg Finak; Nicholas Bertos; Francois Pepin; Svetlana Sadekova; Margarita Souleimanova; Hong Zhao; Haiying Chen; Gulbeyaz Omeroglu; Sarkis Meterissian; Atilla Omeroglu; Michael Hallett; Morag Park
Journal:  Nat Med       Date:  2008-04-27       Impact factor: 53.440

Review 10.  Requirement of macrophages and eosinophils and their cytokines/chemokines for mammary gland development.

Authors:  Valérie Gouon-Evans; Elaine Y Lin; Jeffrey W Pollard
Journal:  Breast Cancer Res       Date:  2002-06-25       Impact factor: 6.466

View more
  22 in total

Review 1.  How Can Advanced Imaging Be Used to Mitigate Potential Breast Cancer Overdiagnosis?

Authors:  Habib Rahbar; Elizabeth S McDonald; Janie M Lee; Savannah C Partridge; Christoph I Lee
Journal:  Acad Radiol       Date:  2016-03-23       Impact factor: 3.173

Review 2.  TRIENNIAL LACTATION SYMPOSIUM/BOLFA: Plasticity of mammary development in the prepubertal bovine mammary gland.

Authors:  R M Akers
Journal:  J Anim Sci       Date:  2017-12       Impact factor: 3.159

Review 3.  Exosomes Derived from Breast Cancer Cells, Small Trojan Horses?

Authors:  Alejandro Villagrasa; Pablo Juan Álvarez; Antonio Osuna; Jose Manuel Garrido; Antonia Aránega; Fernando Rodríguez-Serrano
Journal:  J Mammary Gland Biol Neoplasia       Date:  2015-07-01       Impact factor: 2.673

Review 4.  Induced mammary cancer in rat models: pathogenesis, genetics, and relevance to female breast cancer.

Authors:  James L Miller; Arianna P Bartlett; Rebecca M Harman; Prabin Dhangada Majhi; D Joseph Jerry; Gerlinde R Van de Walle
Journal:  J Mammary Gland Biol Neoplasia       Date:  2022-07-29       Impact factor: 2.698

Review 5.  Key steps for effective breast cancer prevention.

Authors:  Kara L Britt; Jack Cuzick; Kelly-Anne Phillips
Journal:  Nat Rev Cancer       Date:  2020-06-11       Impact factor: 60.716

6.  High mammographic density is associated with an increase in stromal collagen and immune cells within the mammary epithelium.

Authors:  Cecilia W Huo; Grace Chew; Prue Hill; Dexing Huang; Wendy Ingman; Leigh Hodson; Kristy A Brown; Astrid Magenau; Amr H Allam; Ewan McGhee; Paul Timpson; Michael A Henderson; Erik W Thompson; Kara Britt
Journal:  Breast Cancer Res       Date:  2015-06-04       Impact factor: 6.466

7.  Zoledronic acid-encapsulating self-assembling nanoparticles and doxorubicin: a combinatorial approach to overcome simultaneously chemoresistance and immunoresistance in breast tumors.

Authors:  Joanna Kopecka; Stefania Porto; Sara Lusa; Elena Gazzano; Giuseppina Salzano; Martha Leonor Pinzòn-Daza; Antonio Giordano; Vincenzo Desiderio; Dario Ghigo; Giuseppe De Rosa; Michele Caraglia; Chiara Riganti
Journal:  Oncotarget       Date:  2016-04-12

8.  Mammographically dense human breast tissue stimulates MCF10DCIS.com progression to invasive lesions and metastasis.

Authors:  Cecilia W Huo; Mark Waltham; Christine Khoo; Stephen B Fox; Prue Hill; Shou Chen; Grace L Chew; John T Price; Chau H Nguyen; Elizabeth D Williams; Michael Henderson; Erik W Thompson; Kara L Britt
Journal:  Breast Cancer Res       Date:  2016-10-25       Impact factor: 6.466

Review 9.  Breast Cancer-Associated Fibroblasts: Where We Are and Where We Need to Go.

Authors:  Rachel J Buchsbaum; Sun Young Oh
Journal:  Cancers (Basel)       Date:  2016-01-27       Impact factor: 6.639

10.  PTEN Loss in E-Cadherin-Deficient Mouse Mammary Epithelial Cells Rescues Apoptosis and Results in Development of Classical Invasive Lobular Carcinoma.

Authors:  Mirjam C Boelens; Micha Nethe; Sjoerd Klarenbeek; Julian R de Ruiter; Eva Schut; Nicola Bonzanni; Amber L Zeeman; Ellen Wientjens; Eline van der Burg; Lodewyk Wessels; Renée van Amerongen; Jos Jonkers
Journal:  Cell Rep       Date:  2016-08-11       Impact factor: 9.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.